Compare $AORT vs $BBNX | Chartloom

Compare

$AORT vs $BBNX

Artivion Inc · Beta Bionics Inc

AORT

Artivion Inc

BBNX

Beta Bionics Inc

Compare $AORT vs $BBNX

Comparing Artivion Inc and Beta Bionics Inc

AORTArtivion Inc

BBNXBeta Bionics Inc

AORTArtivion Inc

Market cap

$1.03B

P/E (TTM)

—

Forward P/E (NTM)

69.38x

Forward P/S (NTM)

1.96x

Rev growth (TTM)

16.4%

YTD performance

-52.2%

52W performance

-48.1%

FCF yield

-0.9%

BBNXBeta Bionics Inc

Market cap

$793M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.37x

Rev growth (TTM)

94.1%

YTD performance

-39.7%

52W performance

-20.3%

FCF yield

-7.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AORT

BBNX

Detailed metrics comparison

AORT

Artivion Inc

BBNX

Beta Bionics Inc

Market Cap

AORT$1.03B

BBNX$793M

Enterprise Value

AORT$1.32B

BBNX$749M

Price

AORT$21.26

BBNX$17.63

P/E Ratio

AORTN/A

BBNXN/A

P/S Ratio

AORT2.19x

BBNX6.66x

EV/Sales

AORT2.80x

BBNX6.29x

EV/EBITDA

AORT34.60x

BBNX0.00x

P/B Ratio

AORT2.44x

BBNX3.99x

P/FCF Ratio

AORTN/A

BBNXN/A

EV/FCF

AORT-144.34x

BBNX-12.19x

PEG Ratio

AORTN/A

BBNXN/A

Forward P/E (NTM)

AORT69.38x

BBNXN/A

Forward P/S (NTM)

AORT1.96x

BBNX5.37x

Revenue (TTM)

AORT$471M

BBNX$119M

Revenue Growth (YoY)

AORT16.4%

BBNX94.1%

Forward Rev Growth

AORT10.8%

BBNX34.2%

Gross Margin (TTM)

AORT64.4%

BBNX58.3%

Operating Margin (TTM)

AORT2.9%

BBNX0.0%

EBITDA Margin (TTM)

AORT8.1%

BBNX-67.9%

Net Margin (TTM)

AORT-0.7%

BBNX-61.3%

FCF Margin (TTM)

AORT-1.9%

BBNX-51.6%

Net Income (TTM)

AORT$-3M

BBNX$-73M

FCF (TTM)

AORT$-9M

BBNX$-61M

EPS (TTM)

AORT-$0.07

BBNX-$1.64

ROE (TTM)

AORT-71.0%

BBNX-2630.0%

ROA (TTM)

AORT-34.0%

BBNX-2325.0%

ROIC (TTM)

AORT-45.0%

BBNX-2630.0%

Cash

AORT$77M

BBNX$44M

Debt

AORT$367M

BBNX$0

Net Cash/Debt

AORT$-290M

BBNX$44M

Current Ratio (TTM)

AORT3.47x

BBNX8.88x

Quick Ratio (TTM)

AORT2.26x

BBNX7.72x

Debt/Equity (TTM)

AORT0.82x

BBNX0.00x

Debt/Assets (TTM)

AORT0.0%

BBNX0.0%

Interest Coverage (TTM)

AORTN/A

BBNXN/A

Net Debt/EBITDA (TTM)

AORT0.00x

BBNX0.00x

Beta

AORT1.30

BBNX0.92

52W Performance

AORT-48.1%

BBNX-20.3%

YTD Performance

AORT-52.2%

BBNX-39.7%

% from 52W High

AORT-55.9%

BBNX-46.1%

% from 52W Low

AORT11.0%

BBNX100.3%

Asset Turnover (TTM)

AORT0.51x

BBNX0.38x

FCF Yield (TTM)

AORT-0.9%

BBNX-7.7%

Earnings Yield (TTM)

AORT-0.3%

BBNX-9.2%

Dividend Yield (TTM)

AORTN/A

BBNXN/A

Rule of 40

AORT14.5

BBNX42.5

EV/GP/RG

AORT0.37

BBNX0.34

Ticker research

View AORT research View BBNX research

Metric	AORT Artivion Inc	BBNX Beta Bionics Inc
Market & Valuation
Market Cap	$1.03B	$793M
Enterprise Value	$1.32B	$749M
Price	$21.26	$17.63
P/E Ratio	N/A	N/A
P/S Ratio	2.19x	6.66x
EV/Sales	2.80x	6.29x
EV/EBITDA	34.60x	0.00x
P/B Ratio	2.44x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-144.34x	-12.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	69.38x	N/A
Forward P/S (NTM)	1.96x	5.37x
Revenue & Growth
Revenue (TTM)	$471M	$119M
Revenue Growth (YoY)	16.4%	94.1%
Forward Rev Growth	10.8%	34.2%
Profitability
Gross Margin (TTM)	64.4%	58.3%
Operating Margin (TTM)	2.9%	0.0%
EBITDA Margin (TTM)	8.1%	-67.9%
Net Margin (TTM)	-0.7%	-61.3%
FCF Margin (TTM)	-1.9%	-51.6%
Net Income (TTM)	$-3M	$-73M
FCF (TTM)	$-9M	$-61M
EPS (TTM)	-$0.07	-$1.64
ROE (TTM)	-71.0%	-2630.0%
ROA (TTM)	-34.0%	-2325.0%
ROIC (TTM)	-45.0%	-2630.0%
Financial Health
Cash	$77M	$44M
Debt	$367M	$0
Net Cash/Debt	$-290M	$44M
Current Ratio (TTM)	3.47x	8.88x
Quick Ratio (TTM)	2.26x	7.72x
Debt/Equity (TTM)	0.82x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.30	0.92
52W Performance	-48.1%	-20.3%
YTD Performance	-52.2%	-39.7%
% from 52W High	-55.9%	-46.1%
% from 52W Low	11.0%	100.3%
Efficiency & Yields
Asset Turnover (TTM)	0.51x	0.38x
FCF Yield (TTM)	-0.9%	-7.7%
Earnings Yield (TTM)	-0.3%	-9.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.5	42.5
EV/GP/RG	0.37	0.34
Ticker research	View AORT research	View BBNX research

Valuation

P/S Ratio

AORT

2.19x

BBNX

6.66x

EV/FCF

AORT

-144.34x

BBNX

-12.19x

Growth & revenue

Revenue Growth TTM

BBNX

94.1%

AORT

16.4%

Forward Revenue Growth

BBNX

34.2%

AORT

10.8%

Profitability & performance

Gross Margin

AORT

64.4%

BBNX

58.3%

ROE

AORT

-71.0%

BBNX

-2630.0%

FCF Yield %

AORT

-0.9%

BBNX

-7.7%

52-Week Performance

BBNX

-20.3%

AORT

-48.1%

Detailed metrics comparison

AORT

Artivion Inc

BBNX

Beta Bionics Inc

Market Cap

AORT$1.03B

BBNX$793M

Enterprise Value

AORT$1.32B

BBNX$749M

Price

AORT$21.26

BBNX$17.63

P/E Ratio

AORTN/A

BBNXN/A

P/S Ratio

AORT2.19x

BBNX6.66x

EV/Sales

AORT2.80x

BBNX6.29x

EV/EBITDA

AORT34.60x

BBNX0.00x

P/B Ratio

AORT2.44x

BBNX3.99x

P/FCF Ratio

AORTN/A

BBNXN/A

EV/FCF

AORT-144.34x

BBNX-12.19x

PEG Ratio

AORTN/A

BBNXN/A

Forward P/E (NTM)

AORT69.38x

BBNXN/A

Forward P/S (NTM)

AORT1.96x

BBNX5.37x

Revenue (TTM)

AORT$471M

BBNX$119M

Revenue Growth (YoY)

AORT16.4%

BBNX94.1%

Forward Rev Growth

AORT10.8%

BBNX34.2%

Gross Margin (TTM)

AORT64.4%

BBNX58.3%

Operating Margin (TTM)

AORT2.9%

BBNX0.0%

EBITDA Margin (TTM)

AORT8.1%

BBNX-67.9%

Net Margin (TTM)

AORT-0.7%

BBNX-61.3%

FCF Margin (TTM)

AORT-1.9%

BBNX-51.6%

Net Income (TTM)

AORT$-3M

BBNX$-73M

FCF (TTM)

AORT$-9M

BBNX$-61M

EPS (TTM)

AORT-$0.07

BBNX-$1.64

ROE (TTM)

AORT-71.0%

BBNX-2630.0%

ROA (TTM)

AORT-34.0%

BBNX-2325.0%

ROIC (TTM)

AORT-45.0%

BBNX-2630.0%

Cash

AORT$77M

BBNX$44M

Debt

AORT$367M

BBNX$0

Net Cash/Debt

AORT$-290M

BBNX$44M

Current Ratio (TTM)

AORT3.47x

BBNX8.88x

Quick Ratio (TTM)

AORT2.26x

BBNX7.72x

Debt/Equity (TTM)

AORT0.82x

BBNX0.00x

Debt/Assets (TTM)

AORT0.0%

BBNX0.0%

Interest Coverage (TTM)

AORTN/A

BBNXN/A

Net Debt/EBITDA (TTM)

AORT0.00x

BBNX0.00x

Beta

AORT1.30

BBNX0.92

52W Performance

AORT-48.1%

BBNX-20.3%

YTD Performance

AORT-52.2%

BBNX-39.7%

% from 52W High

AORT-55.9%

BBNX-46.1%

% from 52W Low

AORT11.0%

BBNX100.3%

Asset Turnover (TTM)

AORT0.51x

BBNX0.38x

FCF Yield (TTM)

AORT-0.9%

BBNX-7.7%

Earnings Yield (TTM)

AORT-0.3%

BBNX-9.2%

Dividend Yield (TTM)

AORTN/A

BBNXN/A

Rule of 40

AORT14.5

BBNX42.5

EV/GP/RG

AORT0.37

BBNX0.34

Ticker research

View AORT research View BBNX research

Metric	AORT Artivion Inc	BBNX Beta Bionics Inc
Market & Valuation
Market Cap	$1.03B	$793M
Enterprise Value	$1.32B	$749M
Price	$21.26	$17.63
P/E Ratio	N/A	N/A
P/S Ratio	2.19x	6.66x
EV/Sales	2.80x	6.29x
EV/EBITDA	34.60x	0.00x
P/B Ratio	2.44x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-144.34x	-12.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	69.38x	N/A
Forward P/S (NTM)	1.96x	5.37x
Revenue & Growth
Revenue (TTM)	$471M	$119M
Revenue Growth (YoY)	16.4%	94.1%
Forward Rev Growth	10.8%	34.2%
Profitability
Gross Margin (TTM)	64.4%	58.3%
Operating Margin (TTM)	2.9%	0.0%
EBITDA Margin (TTM)	8.1%	-67.9%
Net Margin (TTM)	-0.7%	-61.3%
FCF Margin (TTM)	-1.9%	-51.6%
Net Income (TTM)	$-3M	$-73M
FCF (TTM)	$-9M	$-61M
EPS (TTM)	-$0.07	-$1.64
ROE (TTM)	-71.0%	-2630.0%
ROA (TTM)	-34.0%	-2325.0%
ROIC (TTM)	-45.0%	-2630.0%
Financial Health
Cash	$77M	$44M
Debt	$367M	$0
Net Cash/Debt	$-290M	$44M
Current Ratio (TTM)	3.47x	8.88x
Quick Ratio (TTM)	2.26x	7.72x
Debt/Equity (TTM)	0.82x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.30	0.92
52W Performance	-48.1%	-20.3%
YTD Performance	-52.2%	-39.7%
% from 52W High	-55.9%	-46.1%
% from 52W Low	11.0%	100.3%
Efficiency & Yields
Asset Turnover (TTM)	0.51x	0.38x
FCF Yield (TTM)	-0.9%	-7.7%
Earnings Yield (TTM)	-0.3%	-9.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.5	42.5
EV/GP/RG	0.37	0.34
Ticker research	View AORT research	View BBNX research